Stefana Bucur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Stefana Bucur has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Maria Magdalena Constantin
Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
9 shared publications - Alexandra-Petruta Savu
2nd Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania
6 shared publications - Elena-Daniela Șerban
2nd Department of Dermatology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
6 shared publications - Traian Constantin
Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
6 shared publications - Alin Codrut Nicolescu
Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
5 shared publications - Maria-Diana Ciurduc
Second Department of Dermatology, Colentina Clinical Hospital, 020125 Bucharest, Romania
5 shared publications
Latest Publications
- Open Access
- 25 September 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (19) , 5652
Extraperitoneal Laparoscopic Approach in Inguinal Hernia—The Ideal Solution?
Background: After more than 20 years since laparoscopy was proposed as a solution for one of the most common surgical pathologies, inguinal hernia, the choice of an intra- or extraperitoneal approach has remained a highly debated topic. Purpose and objectives: This study aimed at analyzing the feasibility of the extraperitoneal approach, by routine for this team/ and answering the question of whether this type of approach can be considered a safe one. Although indications for an intra- or extraperitoneal approach largely overlap, it may also be a matter of surgeon preference in choosing one technique. Methods: The study was retrospective, conducted on a group of 493 patients operated on for inguinal hernia in the clinic, by a single operating team, between January 2012 and March 2022. Results: It was proven that out of the 493 surgeries for inguinal hernia, 95.1% (n = 469) were operated upon by laparoscopic TEP (total extra peritoneal patch plasty approach); 1.62% (n = 8) by laparoscopic TAPP (transabdominal intraperitoneal); and 3.24% (n = 16) by the open, anterior approach (Lichtenstein). There were no intraoperative complications recorded in any of the procedures, while postoperative complications were found in 10.23% of cases (n = 48) in the extraperitoneal approach, and recurrences after the TEP approach were recorded in 0.40% of cases (n = 2). Conclusions: For correctly selected cases, TEP hernia surgery can be considered a safe and reliable approach.
- 25 September 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (19) , 5652
Open AccessExtraperitoneal Laparoscopic Approach in Inguinal Hernia—The Ideal Solution?
Background: After more than 20 years since laparoscopy was proposed as a solution for one of the most common surgical pathologies, inguinal hernia, the choice of an intra- or extraperitoneal approach has remained a highly debated topic. Purpose and objectives: This study aimed at analyzing the feasibility of the extraperitoneal approach, by routine for this team/ and answering the question of whether this type of approach can be considered a safe one. Although indications for an intra- or extraperitoneal approach largely overlap, it may also be a matter of surgeon preference in choosing one technique. Methods: The study was retrospective, conducted on a group of 493 patients operated on for inguinal hernia in the clinic, by a single operating team, between January 2012 and March 2022. Results: It was proven that out of the 493 surgeries for inguinal hernia, 95.1% (n = 469) were operated upon by laparoscopic TEP (total extra peritoneal patch plasty approach); 1.62% (n = 8) by laparoscopic TAPP (transabdominal intraperitoneal); and 3.24% (n = 16) by the open, anterior approach (Lichtenstein). There were no intraoperative complications recorded in any of the procedures, while postoperative complications were found in 10.23% of cases (n = 48) in the extraperitoneal approach, and recurrences after the TEP approach were recorded in 0.40% of cases (n = 2). Conclusions: For correctly selected cases, TEP hernia surgery can be considered a safe and reliable approach.
- 23 September 2022
- Published by Morressier GmbH
ESDR164 - Correlations between etiopathogenic factors and persistence of anti-IL-17A biologic therapies in patients with severe psoriasis vulgaris
In recent years, multiple biologic therapies with various mechanisms of action for the treatment of inflammatory diseases have been developed, in | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR164 - Correlations between etiopathogenic factors and persistence of anti-IL-17A biologic therapies in patients with severe psoriasis vulgaris
In recent years, multiple biologic therapies with various mechanisms of action for the treatment of inflammatory diseases have been developed, in | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR071 - A life-threatening rash induced by an inconspicuous drug
Drug-induced rashes are common in the elderly, but some of them can be life-threatening, and for this reason, an appropriate diagnosis and treatm | POSTER
- 22 September 2022
- Published by Morressier GmbH
ESDR071 - A life-threatening rash induced by an inconspicuous drug
Drug-induced rashes are common in the elderly, but some of them can be life-threatening, and for this reason, an appropriate diagnosis and treatm | POSTER
- 21 September 2022
- Published by Morressier GmbH
ESDR422 - Biologic therapy: the last resort in the treatment of chronic spontaneous urticaria
Chronic spontaneous urticaria (CSU) is defined by the presence of recurrent hives, associated in over 60% of cases with angioedema, lasting for m | POSTER
- 21 September 2022
- Published by Morressier GmbH
ESDR422 - Biologic therapy: the last resort in the treatment of chronic spontaneous urticaria
Chronic spontaneous urticaria (CSU) is defined by the presence of recurrent hives, associated in over 60% of cases with angioedema, lasting for m | POSTER
- 19 September 2022
- Published by Morressier GmbH
ESDR067 - Eruptive lichen planus associated with the chronic lymphocytic leukemia: a case report
Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative disease characterized by the accumulation of immature monoclonal lymphocyte | POSTER
- 19 September 2022
- Published by Morressier GmbH
ESDR067 - Eruptive lichen planus associated with the chronic lymphocytic leukemia: a case report
Chronic lymphocytic leukemia (CLL) is a malignant lymphoproliferative disease characterized by the accumulation of immature monoclonal lymphocyte | POSTER
- 19 September 2022
- Published by Morressier GmbH
ESDR505 - Unusual presentation of classic Kaposi`s sarcoma
Kaposi`s sarcoma is vascular neoplasia, with purplish, infiltrative lesions and the possibility of affecting the viscera or lymph nodes, that can | POSTER
- 19 September 2022
- Published by Morressier GmbH
ESDR505 - Unusual presentation of classic Kaposi`s sarcoma
Kaposi`s sarcoma is vascular neoplasia, with purplish, infiltrative lesions and the possibility of affecting the viscera or lymph nodes, that can | POSTER
- 28 August 2022
- Published by Morressier GmbH
ESDR069 - EBA – a dermatological challenge. Clinical case
We present the case of a 71-year-old female patient who was admitted to our clinic for the presence of erythematous-petechial and vesiculo-bullou | POSTER
- 28 August 2022
- Published by Morressier GmbH
ESDR069 - EBA – a dermatological challenge. Clinical case
We present the case of a 71-year-old female patient who was admitted to our clinic for the presence of erythematous-petechial and vesiculo-bullou | POSTER
- Open Access
Oversight and Management of Women with Psoriasis in Childbearing Age
Psoriasis is a complex disease with many associated comorbidities, all of which have a negative impact on a patient’s personal, social, and sexual life. There are some unique considerations in the effects of this disease among women. The average age of diagnosis in women with psoriasis is 28 years, and this onset corresponds to the fertile life of women. There is conflicting information about the effects of psoriasis on female fertility. Some studies suggest that this condition’s associated comorbidities, personal behaviors, and reduced ovarian reserve, especially due to chronic inflammation, affect women’s fertility. Another possible reason women with psoriasis are less likely to become pregnant is that their sexual intercourse frequency decreases after the condition’s onset. The available information on the effects of pregnancy on women with psoriasis is limited. According to current evidence, most women will experience an improvement in their skin condition. Studies show that patients with moderate-to-severe psoriasis are more prone to experience pregnancy complications. The management of pregnant and lactating women with psoriasis is also difficult, as the safety profile of commonly used drugs in patients with psoriasis is not entirely known.
Open AccessOversight and Management of Women with Psoriasis in Childbearing Age
Psoriasis is a complex disease with many associated comorbidities, all of which have a negative impact on a patient’s personal, social, and sexual life. There are some unique considerations in the effects of this disease among women. The average age of diagnosis in women with psoriasis is 28 years, and this onset corresponds to the fertile life of women. There is conflicting information about the effects of psoriasis on female fertility. Some studies suggest that this condition’s associated comorbidities, personal behaviors, and reduced ovarian reserve, especially due to chronic inflammation, affect women’s fertility. Another possible reason women with psoriasis are less likely to become pregnant is that their sexual intercourse frequency decreases after the condition’s onset. The available information on the effects of pregnancy on women with psoriasis is limited. According to current evidence, most women will experience an improvement in their skin condition. Studies show that patients with moderate-to-severe psoriasis are more prone to experience pregnancy complications. The management of pregnant and lactating women with psoriasis is also difficult, as the safety profile of commonly used drugs in patients with psoriasis is not entirely known.
- RetractionOpen Access
- 6 January 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (1) , 110
RETRACTED: Constantin et al. Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762
The journal retracts the article, “Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762”
- 6 January 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (1) , 110
RetractionOpen AccessRETRACTED: Constantin et al. Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762
The journal retracts the article, “Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762”
- RetractedOpen Access
- 24 November 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (12) , 1762
RETRACTED: Animal Models in Bladder Cancer
Background: Bladder cancer (urothelial cancer of the bladder) is the most common malignancy affecting the urinary system with an increasing incidence and mortality. Mouse models of bladder cancer should possess a high value of reproducibility, predictability, and translatability to allow mechanistic, chemo-preventive, and therapeutic studies that can be furthered into human clinical trials. Objectives: To provide an overview and resources on the origin, molecular and pathological characteristics of commonly used animal models in bladder cancer. Methods: A PubMed and Web of Science search was performed for relevant articles published between 1980 and 2021 using words such as: “bladder” and/or “urothelial carcinoma” and animal models. Animal models of bladder cancer can be categorized as autochthonous (spontaneous) and non-autochthonous (transplantable). The first are either chemically induced models or genetically engineered models. The transplantable models can be further subclassified as syngeneic (murine bladder cancer cells implanted into immunocompetent or transgenic mice) and xenografts (human bladder cancer cells implanted into immune-deficient mice). These models can be further divided—based on the site of the tumor—as orthotopic (tumor growth occurs within the bladder) and heterotopic (tumor growth occurs outside of the bladder).
- 24 November 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (12) , 1762
RetractedOpen AccessRETRACTED: Animal Models in Bladder Cancer
Background: Bladder cancer (urothelial cancer of the bladder) is the most common malignancy affecting the urinary system with an increasing incidence and mortality. Mouse models of bladder cancer should possess a high value of reproducibility, predictability, and translatability to allow mechanistic, chemo-preventive, and therapeutic studies that can be furthered into human clinical trials. Objectives: To provide an overview and resources on the origin, molecular and pathological characteristics of commonly used animal models in bladder cancer. Methods: A PubMed and Web of Science search was performed for relevant articles published between 1980 and 2021 using words such as: “bladder” and/or “urothelial carcinoma” and animal models. Animal models of bladder cancer can be categorized as autochthonous (spontaneous) and non-autochthonous (transplantable). The first are either chemically induced models or genetically engineered models. The transplantable models can be further subclassified as syngeneic (murine bladder cancer cells implanted into immunocompetent or transgenic mice) and xenografts (human bladder cancer cells implanted into immune-deficient mice). These models can be further divided—based on the site of the tumor—as orthotopic (tumor growth occurs within the bladder) and heterotopic (tumor growth occurs outside of the bladder).